Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...
For the first time in a decade, U.S. obesity rates have begun to decline, raising hopes that the nation may be turning a ...
Developing brand new drugs is a long ... buying smaller biotechs developing drugs in major markets such as obesity and oncology. 2025's top drug targets Obesity is positioned to be biopharma's ...
Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
This can be explained by the first generation weight loss product that Novo Nordisk had launched, Saxenda (liraglutide), which had been approved by the FDA to treat obesity in 2014. The product ...
Other analysts are more cautious, however, predicting peaks sales of $1 billion or lower and pointing to lacklustre take-up of other new obesity drugs such as Eisai and Arena's Belviq (lorcaserin ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
New Precision Medicine Approach Helps Detect Subgroups of People With Obesity at High Risk of Diabetes ... the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes ...
COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy ... Wegovy is the first-to-market in a new class of highly effective weight-loss drugs. But analysts say that ...
Sowa, a New York University clinical instructor and medical doctor focusing on obesity, offers guidance for those curious about Ozempic and other GLP-1 medications. She provides information about ...